CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenue, Net	$ 2,372.7	$ 2,269.9	$ 7,049.9	$ 6,260.9
Reimbursement Revenue	42.0	47.4	163.5	118.7
Revenues	2,414.7	2,317.3	7,213.4	6,379.6
Cost of sales	1,584.3	1,505.0	4,657.4	4,098.2
Cost of Reimbursable Expense	42.0	47.4	163.5	118.7
Cost of Revenue	1,626.3	1,552.4	4,820.9	4,216.9
Gross profit	788.4	764.9	2,392.5	2,162.7
Selling, general and administrative expenses	400.5	385.6	1,224.2	1,221.9
Amortization of intangibles and other assets	41.1	44.9	130.7	120.6
Net restructuring and other special charges	22.8	26.3	48.6	59.9
Operating Income (Loss)	324.0	308.1	989.0	760.3
Other income (expenses):
Interest expense	(58.2)	(55.9)	(166.2)	(218.1)
Equity method income, net	2.6	2.0	5.9	7.6
Investment income	0.6	0.5	1.5	1.4
Other, net	(5.6)	(3.2)	(1.3)	(4.4)
Earnings before income taxes	263.4	251.5	828.9	546.8
Provision for income taxes	83.6	96.5	280.3	218.3
Net earnings	179.8	155.0	548.6	328.5
Less: Net earnings attributable to the noncontrolling interest	(0.3)	(0.3)	(0.9)	(0.9)
Net earnings attributable to Laboratory Corporation of America Holdings	$ 179.5	$ 154.7	$ 547.7	$ 327.6
Basic earnings per common share (in dollars per share)	$ 1.74	$ 1.53	$ 5.36	$ 3.35
Diluted earnings per common share (in dollars per share)	$ 1.71	$ 1.50	$ 5.25	$ 3.29